mPhase Will Include Research and Development of Drug Delivery Systems to it's Path-Breaking Smart NanoBattery Technology

LITTLE FALLS, New Jersey, June 24, 2013 /PRNewswire/ --



mPhase Technologies, Inc. (OTCQB: XDSL) said today that is broadening it's focus on it's path-breaking battery technology to include research and development of Drug Delivery Systems.

In February of 2013 mPhase filed a United States Letter Patent Application for a novel drug delivery system based on its Smart Surface technology.

The drug delivery patent is based on mPhase's Smart Surface technology enabling the automatic dispensing of a pre set dosage of a drug agent or medication.

mPhase believes the research could lead to a novel drug delivery system possibly creating greater shareholder value.

Last week mPhase received the 2013 North America Frost & Sullivan Technology Innovation Award for its pioneering nanobattery technology.

http://www.frost.com/prod/servlet/pressrelease.pag?docid=279963549

About mPhase Technologies, Inc.

mPhase Technologies (OTCQB: XDSL) is a leading nanotechnology innovator in Smart Surfaces. Potential applications include energy storage systems, drug delivery systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.

In addition to the Smart Surface technology, mPhase, in collaboration with Porsche Design Studio, has developed a world class automotive jump starter. See http://www.mpowertech.com/. More information about the company can be found at http://www.mphasetech.com/.

Forward-Looking Statements: As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.

Contact:
mPhase Technologies, Inc.
Danielle LaSalle
973-256-3737 

SOURCE mPhase Technologies, Inc.